Dimensional Fund Advisors
RLMD icon

Dimensional Fund Advisors’s Relmada Therapeutics RLMD Stock Holding History

Dimensional Fund Advisors’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,428
Closed -$7.5K – 3350
2024
Q4 		$7.5K Sell
14,428
-58,976
-80% -$144K ﹤0.01% 3339
2024
Q3 		$238K Buy
73,404
+4
+0% +$13 ﹤0.01% 3143
2024
Q2 		$220K Sell
73,400
-420
-0.6% -$1.52K ﹤0.01% 3148
2024
Q1 		$343K Hold
73,820
– – ﹤0.01% 3112
2023
Q4 		$305K Hold
73,820
– – ﹤0.01% 3130
2023
Q3 		$221K Sell
73,820
-933
-1% -$2.77K ﹤0.01% 3200
2023
Q2 		$184K Buy
74,753
+19,185
+35% +$53K ﹤0.01% 3247
2023
Q1 		$126K Sell
55,568
-5,065
-8% -$17.5K ﹤0.01% 3276
2022
Q4 		$211 Sell
60,633
-138,267
-70% -$1.21M ﹤0.01% 3217
2022
Q3 		$7.36M Sell
198,900
-2,707
-1% -$75K ﹤0.01% 2283
2022
Q2 		$3.83M Buy
201,607
+80,860
+67% +$1.76M ﹤0.01% 2527
2022
Q1 		$3.26M Buy
120,747
+55,685
+86% +$1.15M ﹤0.01% 2673
2021
Q4 		$1.47M Buy
65,062
+11,858
+22% +$264K ﹤0.01% 2933
2021
Q3 		$1.39M Buy
53,204
+40,239
+310% +$1.08M ﹤0.01% 2956
2021
Q2 		$415K Buy
+12,965
New +$450K ﹤0.01% 3201

Other funds holding RLMD

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return

Dimensional Fund Advisors's RLMD Position: Q1 2025 in Review

Dimensional Fund Advisors sold out of Relmada Therapeutics (RLMD) in Q1 2025, closing a stake of 14,428 shares — an estimated $7.5K sold.

Dimensional Fund Advisors first reported a position in RLMD in Q2 2021 and held it in 15 quarters. The position peaked at $7.36M in Q3 2022. 44 funds tracked by Wall St. Rank hold RLMD as of Q1 2025.

  • Dimensional Fund Advisors reported no remaining Relmada Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 14,428 Relmada Therapeutics shares in Q1 2025, an estimated $7.5K.
  • Dimensional Fund Advisors first reported a position in Relmada Therapeutics in Q2 2021 and held it in 15 quarters.
  • Dimensional Fund Advisors's Relmada Therapeutics position peaked at $7.36M in Q3 2022.
  • 44 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q1 2025.

Based on Dimensional Fund Advisors's 13F filing for Q1 2025, filed 13 May 2025.